LA JOLLA PHARMACEUTICAL CO's ticker is and the CUSIP is 503459954. A total of 3 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2021 | $2,000 | -94.3% | 500 | -94.1% | 0.00% | – |
Q3 2021 | $35,000 | -2.8% | 8,500 | 0.0% | 0.00% | – |
Q2 2021 | $36,000 | -20.0% | 8,500 | +7770.4% | 0.00% | – |
Q1 2021 | $45,000 | +80.0% | 108 | +63.6% | 0.00% | – |
Q4 2020 | $25,000 | -60.9% | 66 | -58.8% | 0.00% | – |
Q3 2020 | $64,000 | -66.0% | 160 | -63.9% | 0.00% | – |
Q2 2020 | $188,000 | -0.5% | 443 | -2.0% | 0.00% | – |
Q1 2020 | $189,000 | +136.2% | 452 | +119.4% | 0.00% | – |
Q4 2019 | $80,000 | +95.1% | 206 | +338.3% | 0.00% | – |
Q3 2019 | $41,000 | -74.4% | 47 | -73.0% | 0.00% | – |
Q2 2019 | $160,000 | +661.9% | 174 | +427.3% | 0.00% | – |
Q1 2019 | $21,000 | +425.0% | 33 | +560.0% | 0.00% | – |
Q4 2018 | $4,000 | -50.0% | 5 | +66.7% | 0.00% | – |
Q2 2018 | $8,000 | -94.1% | 3 | -99.5% | 0.00% | -100.0% |
Q1 2018 | $136,000 | +151.9% | 570 | +115.9% | 0.01% | +200.0% |
Q4 2017 | $54,000 | 0.0% | 264 | -37.7% | 0.00% | 0.0% |
Q3 2017 | $54,000 | +800.0% | 424 | +387.4% | 0.00% | – |
Q2 2017 | $6,000 | -96.0% | 87 | -67.3% | 0.00% | -100.0% |
Q1 2017 | $151,000 | +235.6% | 266 | +504.5% | 0.01% | +133.3% |
Q4 2016 | $45,000 | +28.6% | 44 | -27.9% | 0.00% | +50.0% |
Q3 2016 | $35,000 | +3400.0% | 61 | +662.5% | 0.00% | – |
Q2 2016 | $1,000 | – | 8 | +100.0% | 0.00% | – |
Q1 2016 | $0 | -100.0% | 4 | -94.4% | 0.00% | -100.0% |
Q3 2015 | $29,000 | +383.3% | 72 | -60.2% | 0.00% | +100.0% |
Q2 2015 | $6,000 | +100.0% | 181 | +1106.7% | 0.00% | – |
Q1 2015 | $3,000 | – | 15 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 336 | $589,000 | 0.03% |
SIMPLEX TRADING, LLC | 44 | $45,000 | 0.00% |
GROUP ONE TRADING, L.P. | 10,700 | $188,000 | 0.00% |